Literature DB >> 22481605

Prevalence and correlates of HIV and HCV infection among amphetamine-type stimulant users in 6 provinces in China.

Yan-Ping Bao1, Zhi-Min Liu, Zhi Lian, Jian-Hua Li, Rui-Min Zhang, Cong-Bin Zhang, Wei Hao, Xu-Yi Wang, Min Zhao, Hai-Feng Jiang, Shi-Yan Yan, Qing-Liang Wang, Zhi Qu, Hao-Ran Zhang, Ping Wu, Jie Shi, Lin Lu.   

Abstract

BACKGROUND: China has experienced an epidemic of amphetamine-type stimulant (ATS) use in recent years. The present study explored the status and correlates of HIV and hepatitis C virus (HCV) infection among ATS users in China.
METHODS: A multicenter cross-sectional study of HIV and HCV status and associated behaviors among ATS users was conducted in 6 provinces from September 2009 to December 2010. Socioeconomic/behavioral risk factors were measured. Blood samples were collected to test for HIV and HCV antibodies.
RESULTS: Of the 1327 ATS users, the prevalence of HIV and exposure to HCV were 4.5% and 43.5%, respectively, with large geographic variations (0%-20.3% and 8.6%-67.1%, respectively). HIV infection was independently associated with living in Yunnan province [adjusted odds ratio = 15.8; 95% confidence interval (CI): 2.0 to 125.1), polydrug use (adjusted odds ratio = 2.6; 95% CI: 1.3 to 5.4), increased frequency of sexual behavior (adjusted odds ratio = 2.0; 95% CI: 1.1 to 4.1), history of sex with sexually transmitted infection-positive persons (adjusted odds ratio = 11.4; 95% CI: 1.3 to 98.9), and HCV infection (adjusted odds ratio = 2.8; 95% CI: 1.2 to 6.7). HCV was associated with study site, marital status, unemployment (adjusted odds ratio = 1.8; 95% CI: 1.3 to 2.4), a longer duration of ATS use, and history of injection use of ATS (adjusted odds ratio = 13.3; 95% CI: 1.5 to 116.1).
CONCLUSIONS: The prevalence of HIV was high among ATS users in Yunnan province but quite rare elsewhere, and the prevalence of exposure to HCV was high in 6 provinces. Risk factors emphasize the need for new prevention strategies toward this population at risk in China.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22481605     DOI: 10.1097/QAI.0b013e31825694f2

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  10 in total

1.  Co-infections of tuberculosis, hepatitis B or C viruses in a cohort of people living with HIV/AIDS in China: predictors and sequelae.

Authors:  Chen Zhang; Xiaoming Li; Yu Liu; Shan Qiao; Yi Chen; Yuejiao Zhou; Zhiyong Shen
Journal:  AIDS Care       Date:  2016-12-21

2.  Use trajectories of amphetamine-type stimulants (ATS) in Shanghai, China.

Authors:  Jiang Du; Haiming Sun; David Huang; Haifeng Jiang; Na Zhong; Ding Xu; Yan Zhao; Shuxing Lin; Wenwen Wang; Zheyi Du; Min Zhao; Yih-Ing Hser
Journal:  Drug Alcohol Depend       Date:  2014-07-04       Impact factor: 4.492

3.  The Spatial Distribution of Hepatitis C Virus Infections and Associated Determinants--An Application of a Geographically Weighted Poisson Regression for Evidence-Based Screening Interventions in Hotspots.

Authors:  Boris Kauhl; Jeanne Heil; Christian J P A Hoebe; Jürgen Schweikart; Thomas Krafft; Nicole H T M Dukers-Muijrers
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

4.  The impact of social factors on human immunodeficiency virus and hepatitis C virus co-infection in a minority region of Si-chuan, the People's Republic of China: a population-based survey and testing study.

Authors:  Caiting Dong; Z Jennifer Huang; Maria C Martin; Jun Huang; Honglu Liu; Bin Deng; Wenhong Lai; Li Liu; Yihui Yang; Ying Hu; Guangming Qin; Linglin Zhang; Zhibin Song; Daying Wei; Lei Nan; Qixing Wang; Hongxia Deng; Jianxun Zhang; Frank Y Wong; Wen Yang
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

5.  Risk Factors of Hepatitis C Virus Infection in Drug Users From Eleven Methadone Maintenance Treatment Clinics in Xi'an, China.

Authors:  Wei Xiaoli; Wang Lirong; Wang Xueliang; Li Jinsong; Li Hengxin; Jia Wei
Journal:  Hepat Mon       Date:  2014-11-23       Impact factor: 0.660

6.  Hepatitis C virus genotypes and subtypes circulating in Mainland China.

Authors:  Ying Chen; Changshun Yu; Xueru Yin; Xiaolei Guo; Shangwei Wu; Jinlin Hou
Journal:  Emerg Microbes Infect       Date:  2017-11-01       Impact factor: 7.163

7.  Prevalence and correlates of HIV infection among people who use drugs in Cambodia: a cross-sectional survey using respondent driven sampling method.

Authors:  Sovannary Tuot; Gitau Mburu; Phalkun Mun; Pheak Chhoun; Navy Chann; Kiesha Prem; Siyan Yi
Journal:  BMC Infect Dis       Date:  2019-06-11       Impact factor: 3.090

8.  Estimating the prevalence of hepatitis C among intravenous drug users in upper middle income countries: A systematic review and meta-analysis.

Authors:  Víctor Granados-García; Yvonne N Flores; Lizbeth I Díaz-Trejo; Lucia Méndez-Sánchez; Stephanie Liu; Guillermo Salinas-Escudero; Filiberto Toledano-Toledano; Jorge Salmerón
Journal:  PLoS One       Date:  2019-02-26       Impact factor: 3.240

9.  The risks of HCV infection among Brazilian crack cocaine users: incorporating diagnostic test uncertainty.

Authors:  Carolina Coutinho; Leonardo S Bastos; Jurema Corrêa da Mota; Lidiane Toledo; Katia Costa; Neilane Bertoni; Francisco I Bastos
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

10.  Patterns of Risky Sexual Behaviors and Associated Factors among Youths and Adolescents in Vietnam.

Authors:  Ha Ngoc Do; Diep Ngoc Nguyen; Hoa Quynh Thi Nguyen; Anh Tuan Nguyen; Hiep Duy Nguyen; Thanh Phuong Bui; Thao Bich Thi Vu; Khiet Thanh Le; Dung Tuan Nguyen; Cuong Tat Nguyen; Linh Gia Vu; Giang Thu Vu; Bach Xuan Tran; Carl A Latkin; Roger C M Ho; Cyrus S H Ho
Journal:  Int J Environ Res Public Health       Date:  2020-03-14       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.